ET Pharma

AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination

Oct 2, 2026, 6:17 PM

Translate article text

Choose a language and wait for the translated text.

The companies said that they intend to begin with a late-stage trial testing the therapies in first-line triple-negative breast cancer